These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32910277)

  • 1. Chemoradiation for Patients with Resected Biliary Tract Cancers in the Adjuvant Setting: Reply to a Letter to the Editor.
    Dee EC; Freret ME; Wo JY
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):937-939. PubMed ID: 32910277
    [No Abstract]   [Full Text] [Related]  

  • 2. Do Any Subgroups of Resected Biliary Tract Cancers Patients That Benefit the Most from Adjuvant Chemoradiation Therapy?
    Ma WJ; Zhou RX
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):934-936. PubMed ID: 32918179
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
    Kim H; Heo MH; Kim JY
    BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASO Author Reflections: Adjuvant Chemoradiation in Resected Biliary Cancers-Insights and Implications.
    Dominguez DA; Melstrom LG
    Ann Surg Oncol; 2024 Aug; 31(8):4942-4943. PubMed ID: 38472671
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant therapy for resected biliary tract cancer: a review.
    Doherty MK; Knox JJ
    Chin Clin Oncol; 2016 Oct; 5(5):64. PubMed ID: 27701873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary tract: Is there a role for neoadjuvant and adjuvant therapy in biliary cancer?
    Jarnagin WR
    Nat Rev Gastroenterol Hepatol; 2012 Nov; 9(11):622-3. PubMed ID: 23007479
    [No Abstract]   [Full Text] [Related]  

  • 7. Defining and Refining the Role of Adjuvant Chemoradiation for Biliary Tract Cancers After SWOG 0809.
    Acidi B; Tran Cao HS
    Ann Surg Oncol; 2024 Aug; 31(8):4837-4838. PubMed ID: 38698283
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis.
    Ghidini M; Tomasello G; Botticelli A; Barni S; Zabbialini G; Seghezzi S; Passalacqua R; Braconi C; Petrelli F
    HPB (Oxford); 2017 Sep; 19(9):741-748. PubMed ID: 28684194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers.
    Dee EC; Freret ME; Wo JY
    Ann Surg Oncol; 2020 Dec; 27(13):5173-5174. PubMed ID: 32748150
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
    Belkouz A; Wilmink JW; Haj Mohammad N; Hagendoorn J; de Vos-Geelen J; Dejong CHC; Homs MYV; Groot Koerkamp B; van Gulik TM; van Oijen MGH; Punt CJA; Klümpen H
    Crit Rev Oncol Hematol; 2020 Jul; 151():102975. PubMed ID: 32464483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoradiation for pancreatic and biliary cancer: current status of RTOG studies.
    Rich TA
    Ann Oncol; 1999; 10 Suppl 4():231-3. PubMed ID: 10436829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Failure and Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation.
    Shulman RM; Meyer JE
    Ann Surg Oncol; 2020 Dec; 27(13):4867-4869. PubMed ID: 32804323
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancers of the biliary system.
    Malka D; Dromain C; Landi B; Prat F; De Baere T; Delpero JR; Chiche L
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S62-2S74. PubMed ID: 17151565
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcome of adjuvant therapy in biliary tract cancers.
    McNamara MG; Walter T; Horgan AM; Amir E; Cleary S; McKeever EL; Min T; Wallace E; Hedley D; Krzyzanowska M; Moore M; Gallinger S; Greig P; Serra S; Dawson LA; Knox JJ
    Am J Clin Oncol; 2015 Aug; 38(4):382-7. PubMed ID: 24572429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic and hepatobiliary cancers: adjuvant therapy and management of inoperable disease.
    Glimelius B
    Ann Oncol; 2000; 11 Suppl 3():153-9. PubMed ID: 11079133
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation.
    Dee EC; Freret ME; Horick N; Raldow AC; Goyal L; Zhu AX; Parikh AR; Ryan DP; Clark JW; Allen JN; Ferrone CR; Fernandez-Del Castillo C; Tanabe KK; Drapek LC; Hong TS; Qadan M; Wo JY
    Ann Surg Oncol; 2020 Dec; 27(13):5161-5172. PubMed ID: 32740733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality Management of Localized Biliary Cancer.
    Ashai N; Prasad P; Rajdev L
    Curr Treat Options Oncol; 2019 May; 20(7):58. PubMed ID: 31144050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current standards and future perspectives in adjuvant treatment for biliary tract cancers.
    Lamarca A; Edeline J; McNamara MG; Hubner RA; Nagino M; Bridgewater J; Primrose J; Valle JW
    Cancer Treat Rev; 2020 Mar; 84():101936. PubMed ID: 31986437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.
    Nakachi K; Konishi M; Ikeda M; Shimada K; Okusaka T; Saiura A; Ishii H; Sugiyama M; Furuse J; Sakamoto H; Shimamura T; Ohta T
    Int J Clin Oncol; 2018 Oct; 23(5):894-899. PubMed ID: 29705976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: Adjuvant Chemotherapy for Resected Biliary Tract Cancers-Does One Size Fit All?
    Rhodin KE; Lidsky ME
    Ann Surg Oncol; 2023 Aug; 30(8):4822-4823. PubMed ID: 37149546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.